OBJECTIVES: Preliminary assessment of the adequacy of AIDS surveillance efforts in Europe by comparing data from two official sources-AIDS surveillance and mortality statistics. METHODS: The study used ENAADS (European Non-Aggregate AIDS Data Set) data compiled by the European Centre for the Epidemiological Monitoring of AIDS in St Maurice, France, and mortality statistics from WHO. As ENAADS provides information about AIDS incidence as well as AIDS mortality, both series were compared with WHO mortality data. Western European countries with more than 1000 adult AIDS cases as of July 1997 were included in the cross country comparative analyses. RESULTS: AIDS surveillance and mortality statistics in Europe depict four different patterns: (1) high overall concordance (Austria, Italy, Switzerland); (2) concordance between incidence by ENAADS and mortality by WHO, but a delay in mortality reporting in ENAADS (France, Spain); (3) more cases in WHO mortality data than in ENAADS data (Germany, Portugal); (4) more cases in ENAADS data than in WHO mortality data (Sweden, United Kingdom, Greece, Belgium). CONCLUSIONS: National AIDS surveillance systems in Europe exhibit important differences in terms of completeness and functionality. New challenges such as the introduction of effective but expensive and complex treatments will exert demands on surveillance efforts. Countries with discrepant AIDS and mortality data should try to improve and update their surveillance systems.
OBJECTIVES: Preliminary assessment of the adequacy of AIDS surveillance efforts in Europe by comparing data from two official sources-AIDS surveillance and mortality statistics. METHODS: The study used ENAADS (European Non-Aggregate AIDS Data Set) data compiled by the European Centre for the Epidemiological Monitoring of AIDS in St Maurice, France, and mortality statistics from WHO. As ENAADS provides information about AIDS incidence as well as AIDS mortality, both series were compared with WHO mortality data. Western European countries with more than 1000 adult AIDS cases as of July 1997 were included in the cross country comparative analyses. RESULTS:AIDS surveillance and mortality statistics in Europe depict four different patterns: (1) high overall concordance (Austria, Italy, Switzerland); (2) concordance between incidence by ENAADS and mortality by WHO, but a delay in mortality reporting in ENAADS (France, Spain); (3) more cases in WHO mortality data than in ENAADS data (Germany, Portugal); (4) more cases in ENAADS data than in WHO mortality data (Sweden, United Kingdom, Greece, Belgium). CONCLUSIONS: National AIDS surveillance systems in Europe exhibit important differences in terms of completeness and functionality. New challenges such as the introduction of effective but expensive and complex treatments will exert demands on surveillance efforts. Countries with discrepant AIDS and mortality data should try to improve and update their surveillance systems.
Authors: N Montellá i Jordana; I Ricart de Mesones; C Borrell i Thió; R Clos i Guix; J A Caylà i Buqueras Journal: Rev Sanid Hig Publica (Madr) Date: 1995 Jan-Feb
Authors: R Colebunders; D Kintin; Y Fleerackers; T Demeulenaere; M Vandenbruaene; J Goeman; L Kestens; C M Farber; F Soete Journal: Lancet Date: 1993-10-02 Impact factor: 79.321
Authors: Manuela García de la Hera; Inmaculada Ferreros; Julia del Amo; Patricia García de Olalla; Santiago Pérez Hoyos; Roberto Muga; Jorge del Romero; Rafael Guerrero; Ildefonso Hernández-Aguado Journal: J Epidemiol Community Health Date: 2004-11 Impact factor: 3.710
Authors: Christopher G Au-Yeung; Aranka Anema; Keith Chan; Benita Yip; Julio S G Montaner; Robert S Hogg Journal: BMC Public Health Date: 2010-10-25 Impact factor: 3.295
Authors: J del Amo; J del Romero; A Barrasa; S Pérez-Hoyos; C Rodríguez; M Díez; S García; V Soriano; J Castilla Journal: Sex Transm Infect Date: 2002-08 Impact factor: 3.519
Authors: L Dal Maso; S Franceschi; J Polesel; C Braga; P Piselli; E Crocetti; F Falcini; S Guzzinati; R Zanetti; M Vercelli; G Rezza Journal: Br J Cancer Date: 2003-07-07 Impact factor: 7.640
Authors: L Dal Maso; J Polesel; V Ascoli; P Zambon; M Budroni; S Ferretti; R Tumino; G Tagliabue; S Patriarca; M Federico; M Vercelli; A Giacomin; G Vicario; F Bellù; F Falcini; E Crocetti; V De Lisi; S Vitarelli; S Piffer; F Stracci; D Serraino; G Rezza; S Franceschi Journal: Br J Cancer Date: 2005-01-17 Impact factor: 7.640